Dan Mitchell

Dan is an experienced financial writer and market commentator with a background in digital assets and cryptocurrency markets. Blending macro fundamentals with technical chart work, he distils market developments into practical commentary for retail traders.

Experience

Dan began reporting on blockchain technology and cryptocurrencies in 2018, writing news, features, and analysis for Binance and Cointelegraph, alongside several other specialist outlets. He joined Capital.com in 2024.

Education

Bachelor of Arts in English Literature and Journalism, University of Winchester

Expertise

  • Digital assets
  • Cryptocurrency markets
  • Financial derivatives
  • Fundamental analysis
  • Technical analysis
  • Risk management

Social network (Twitter / Linkedin)

Linkedin: Connect with Dan on LinkedIn

Articles by Dan Mitchell

Contemporary Amperex (CATL) stock forecast
Contemporary Amperex (CATL) stock forecast: Third-party price targets
Contemporary Amperex Technology (3750) is a China-based battery manufacturer listed in Hong Kong and Shenzhen, supplying lithium-ion batteries for electric vehicles and energy-storage systems globally. Explore third-party 3750 price targets and technical analysis.
13:34, 18 February 2026
Merck stock forecast: Third-party price targets
Merck stock forecast: Third-party price targets
Merck & Company is a US pharmaceutical company listed on the NYSE, with operations spanning oncology, vaccines and prescription medicines, and a share price influenced by earnings results, clinical data and policy developments. Explore third-party MRK price targets and technical analysis.
13:19, 18 February 2026
Meta Platforms stock forecast
Meta Platforms stock forecast: Third-party price targets
Meta Platforms is a US-listed technology company that generates most of its revenue from digital advertising across its social media platforms, while investing heavily in artificial intelligence and related infrastructure. Explore third-party META price targets and technical analysis.
13:09, 18 February 2026
D-Wave Quantum stock forecast
D-Wave Quantum stock forecast: Third-party price targets
D-Wave Quantum is a US-listed quantum computing company that develops annealing and gate-based systems, generating revenue through cloud-based services, research partnerships and enterprise contracts. Explore third-party QBTS price targets and technical analysis.
12:20, 18 February 2026
Zcash price prediction
Zcash price prediction: Third-party outlook
Zcash (ZEC) is a decentralised cryptocurrency launched in 2016, designed to offer optional transaction privacy, and it trades on major crypto exchanges against the US dollar and other digital assets. Explore third-party ZEC price targets and technical analysis.
12:08, 18 February 2026
Visa stock forecast
Visa stock forecast: Third-party price targets
Visa Inc. is a US-listed global payments technology company that operates a worldwide card network, processing electronic transactions between consumers, businesses and financial institutions. Explore third-party V price targets and technical analysis.
11:47, 18 February 2026
Pi Network price prediction
Pi Network price prediction: Third-party outlook
Explore third-party PI price targets and technical analysis.
11:35, 18 February 2026
Uniswap price prediction
Uniswap price prediction: Third-party outlook
Uniswap is a decentralised exchange protocol on the Ethereum blockchain, with its UNI token used for governance and influenced by protocol activity and wider crypto market conditions. Explore third-party UNI price targets and technical analysis.
15:28, 17 February 2026
Allianz logo displayed on the exterior of a modern office building under a clear blue sky.
Allianz stock forecast: Third-party price targets
Allianz SE is a Germany-based financial services group listed on Xetra, operating across insurance and asset management with a broad international presence and diversified revenue streams. Explore third-party ALV price targets and technical analysis.
15:08, 17 February 2026
BioNtech stock forecast
BioNtech stock forecast: Third-party price targets
BioNTech (BNTX) is a biotechnology company developing mRNA-based therapies and vaccines, with a growing oncology pipeline and shares listed on Nasdaq. Explore third-party BNTX price targets and technical analysis.
14:51, 17 February 2026

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading